in animals clearing 12.5 mg. or more of bsa per day ( excluding those dying of anaphylaxis or unknown causes ) , marked differences were noted in the incidence of membranous glomerulonephritis ( gln ) ( 50 per cent in group i versus 15.4 per cent in group ii ) , of crescentic gln ( none in group i versus 26.9 per cent in group ii ) , and of mesangiopathic gln ( 11.1 per cent in group i versus 30.8 per cent in group ii ) .
C0403416
crescentic
C0017658
gln